BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32448364)

  • 1. Intracellular functions of RNA-binding protein, Musashi1, in stem and cancer cells.
    Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Gure AO; Ghaedi K
    Stem Cell Res Ther; 2020 May; 11(1):193. PubMed ID: 32448364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.
    Vo DT; Qiao M; Smith AD; Burns SC; Brenner AJ; Penalva LO
    RNA Biol; 2011; 8(5):817-28. PubMed ID: 21881409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway.
    Lang Y; Kong X; He C; Wang F; Liu B; Zhang S; Ning J; Zhu K; Xu S
    Cell Physiol Biochem; 2017; 44(2):455-466. PubMed ID: 29141252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b.
    Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Ghaedi K
    BMC Mol Cell Biol; 2021 Feb; 22(1):10. PubMed ID: 33541259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.
    Yi C; Li G; Ivanov DN; Wang Z; Velasco MX; Hernández G; Kaundal S; Villarreal J; Gupta YK; Qiao M; Hubert CG; Hart MJ; Penalva LOF
    RNA Biol; 2018; 15(11):1420-1432. PubMed ID: 30362859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival.
    Wang XY; Penalva LO; Yuan H; Linnoila RI; Lu J; Okano H; Glazer RI
    Mol Cancer; 2010 Aug; 9():221. PubMed ID: 20727204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.
    Muto J; Imai T; Ogawa D; Nishimoto Y; Okada Y; Mabuchi Y; Kawase T; Iwanami A; Mischel PS; Saya H; Yoshida K; Matsuzaki Y; Okano H
    PLoS One; 2012; 7(3):e33431. PubMed ID: 22428049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1.
    Lan L; Appelman C; Smith AR; Yu J; Larsen S; Marquez RT; Liu H; Wu X; Gao P; Roy A; Anbanandam A; Gowthaman R; Karanicolas J; De Guzman RN; Rogers S; Aubé J; Ji M; Cohen RS; Neufeld KL; Xu L
    Mol Oncol; 2015 Aug; 9(7):1406-20. PubMed ID: 25933687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.
    Sanchez-Diaz PC; Burton TL; Burns SC; Hung JY; Penalva LO
    BMC Cancer; 2008 Sep; 8():280. PubMed ID: 18826648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer.
    Wang XY; Yu H; Linnoila RI; Li L; Li D; Mo B; Okano H; Penalva LO; Glazer RI
    Oncotarget; 2013 May; 4(5):739-50. PubMed ID: 23715514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development.
    Velasco MX; Kosti A; Guardia GDA; Santos MC; Tegge A; Qiao M; Correa BRS; Hernández G; Kokovay E; Galante PAF; Penalva LOF
    RNA; 2019 Jul; 25(7):768-782. PubMed ID: 31004009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
    Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
    Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways.
    Wang XY; Yin Y; Yuan H; Sakamaki T; Okano H; Glazer RI
    Mol Cell Biol; 2008 Jun; 28(11):3589-99. PubMed ID: 18362162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells.
    Vo DT; Abdelmohsen K; Martindale JL; Qiao M; Tominaga K; Burton TL; Gelfond JA; Brenner AJ; Patel V; Trageser D; Scheffler B; Gorospe M; Penalva LO
    Mol Cancer Res; 2012 Jan; 10(1):143-55. PubMed ID: 22258704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Musashi1 regulates survival of hepatoma cell lines by activation of Wnt signalling pathway.
    Chen K; Gao Q; Zhang W; Liu Z; Cai J; Liu Y; Xu J; Li J; Yang Y; Xu X
    Liver Int; 2015 Mar; 35(3):986-98. PubMed ID: 24444033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory factor X transcription factors control Musashi1 transcription in mouse neural stem/progenitor cells.
    Kawase S; Kuwako K; Imai T; Renault-Mihara F; Yaguchi K; Itohara S; Okano H
    Stem Cells Dev; 2014 Sep; 23(18):2250-61. PubMed ID: 25058468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast Cancer.
    Haiduk TS; Sicking M; Brücksken KA; Espinoza-Sánchez NA; Eder KM; Kemper B; Eich HT; Götte M; Greve B; Troschel FM
    Arch Med Res; 2023 Sep; 54(6):102855. PubMed ID: 37481823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.
    Shi C; Zhang Z
    Tumour Biol; 2016 Apr; 37(4):5437-43. PubMed ID: 26563371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation.
    Rezza A; Skah S; Roche C; Nadjar J; Samarut J; Plateroti M
    J Cell Sci; 2010 Oct; 123(Pt 19):3256-65. PubMed ID: 20826465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.